The Pharmaceuticals initiative of Reliance Life Sciences is focused on developing Active Pharmaceutical Ingredients (API) and Formulations for domestic and global markets in the categories of:

• Oncology products
• Steroids
• Hyaluronate Injection

Reliance Life Sciences markets APIs in the categories listed above and the following formulated products:

• Formulations
• TemoRel^® (Temozolomide)
• ReliCitabine^® (Capecitabine)
• ReliTrexed^® (Pemetrexed)
• ImatiRel^® (Imatinib mesylate)
• SynoLife™ / SynoLife One™ (Hyaluronate Injection)
• ReliPac™  (Paclitaxel)
• ReliDoce™ (Docetaxel)
• ReliTecan™ (Irinotecan hydrochloride)

These products are manufactured in cGMP facilities:

• Plant 3 - Kilo scale facility for Pharmaceutical APIs with containment facilities for oncology products at Dhirubhai Ambani Life Sciences Center, Navi Mumbai.



• Plant 6 - A manufacturing facility for oncology formulations (oral solid dosages and injectibles) at  Dhirubhai Ambani Life Sciences Center, Navi Mumbai

To know more about Pharmaceutical products click here